The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
Open accessAbstract
The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The truth about the drug companies: how they deceive us and what to do about it
(2005) · Choice Reviews Online · doi:10.5860/choice.42-5297 · Cited by 885
The Truth About Drug Companies: How They Deceive Us and What to Do About It.
Henderson, S. W. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000157547.41337.46 · Cited by 506
Financialization and Strategy: Narrative and Numbers
Froud, J., Johal, S., Leaver, A., & Williams, K. (2006) · Routledge eBooks · doi:10.4324/9780203414941 · Cited by 488
Financialization and Strategy: Narrative and Numbers
Froud, J., Johal, S., Leaver, A., et al. (2006) · Cited by 399
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
Steinman, M. A., Bero, L. A., Chren, M.-M., & Landefeld, C. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00008 · Cited by 336
Ghost Authorship in Industry-Initiated Randomised Trials
Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A.-W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040019 · Cited by 289 · cited 1×
“There are other avenues for promotion that would not be captured by either IMS or CAM, such as ghostwriting [16] and illegal off-label promotion [17].”
BackgroundPharmaceutical Industry Profile
(2005) · Good Design Practices for GMP Pharmaceutical Facilities · doi:10.1201/9780849398537-6 · Cited by 179
Cited by
Spurling, G. K., Mansfield, P. R., Montgomery, B. D., Lexchin, J., Doust, J., Othman, N., & Vitry, A. I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000352 · Cited by 526
Self-citationPrasad, V., & Mailankody, S. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3601 · Cited by 503
Pharmaceutical research and development: what do we get for all that money?
Light, D. W., & Lexchin, J. R. (2012) · BMJ · doi:10.1136/bmj.e4348 · Cited by 258
Self-citationTarning, J., McGready, R., Lindegardh, N., Ashley, E. A., Pimanpanarak, M., Kamanikom, B., Annerberg, A., Day, N. P. J., Stepniewska, K., Singhasivanon, P., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00195-09 · Cited by 99
Wagner, G., Schultes, M.-T., Titscher, V., Teufer, B., Klerings, I., & Gartlehner, G. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.056 · Cited by 61
Metadata
- Authors
- Gagnon, M.-A., & Lexchin, J.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-01-03
- Volume
- 5
- Issue
- 1
- Pages
- e1
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2039415645
- Cited by
- 502
- References
- 7
- FWCI
- 27.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. https://app.cochat.ai/papers/10.1371/journal.pmed.0050001
- The paper
- Gagnon, M.-A., & Lexchin, J. (2008). The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0050001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
